Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cholestyramine on serum persistent organic pollutants in obese patients
2023-505116-37-00Phase 2Authorised
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jun 2023
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2 trial of cholestyramine in obesity, sponsored by Centre Hospitalier Universitaire de Nice. Planned start Jun 2023; status: authorised.
02
Drugs
cholestyramine
03
Conditions
obesity
Beyond the preview
Go deeper on 2023-505116-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-505116-37-00.